CN Mobile Logo


Anna Azvolinsky, PhD

Anna Azvolinsky, PhD

Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.

Follow Her on Twitter

Posts by Author

Nivolumab Trumps Ipilimumab for Treatment-Naive Metastatic Melanoma

This slide show highlights some of the top studies and news on cancer to come out of the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago.

The FDA has granted a priority review for MM-398 as a second-line treatment for metastatic pancreatic cancer after the drug demonstrated improved survival.

Frequent consumers of citrus fruits were found to have an elevated risk of malignant melanoma.

Detection of cervical lesions among young women has decreased since the introduction of HPV vaccines and guidelines calling for reduced cervical cancer screening.

A study of men taking PDE5 inhibitors found a small but significant increase in the incidence of malignant melanoma, though the association may not be causal.

The presence of an abdominal blood clot may be a sign of cancer and may also be associated with poor survival for patients with pancreatic or liver cancers.

Detection of antibodies against HPV16 in the blood of patients with HPV-positive oropharyngeal carcinoma correlates with improved survival.

Utilization of breast-conserving therapy has increased over the years in early breast cancer but there are still barriers, including socioeconomic factors.

PSA-based screening for prostate cancer among men older than 50 has decreased since the 2012 USPSTF recommendations.

A large randomized trial showed that three different bisphosphonates have similar efficacy in early-stage breast cancer.


By clicking Accept, you agree to become a member of the UBM Medica Community.